Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11744879 Recombinant FSH composition for controlled ovarian stimulation

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
August 31, 2018
Date of Patent
September 5, 2023
Patent Application Number
16642777
Patent Citations
‌
US Patent 8951967 Recombinant FSH including alpha 2,3- and alpha 2,6-sailylation
‌
US Patent 9320778 Method for controlled ovarian stimulation with combined FSH and hCG
‌
US Patent 9546204 Recombinant FSH including alpha 2,3- and alpha 2,6-sialylation
‌
US Patent 9694052 FSH composition and methods for controlled ovarian stimulation
‌
US Patent 9771407 Pharmaceutical preparation
‌
US Patent 10064920 Method for controlled ovarian stimulation using FSH and hCG
‌
US Patent 10413592 Methods of treating infertility
‌
US Patent 10464984 Optimized nucleic acid sequences coding for the alpha-chain of human chorionic gonadotropin
‌
US Patent 10624953 Human-derived recombinant FSH for controlled ovarian stimulation
‌
US Patent 10660938 Recombinant FSH composition for treatment of infertility
•••
Patent Inventor Names
Lisbeth Helmgaard
Bjarke Mirner Klein
Joan-Carles Arce Saez
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11744879
Patent Primary Examiner
‌
Christina M Borgeest

Find more entities like US Patent 11744879 Recombinant FSH composition for controlled ovarian stimulation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo